Clinical trials

  • DUVAKITUG (Human IgG1 lambda monoclonal antibody against TL1A/TNFSF15) for Ulcerative colitis
  • MIRIKIZUMAB for Ulcerative colitis | Obesity
  • Nitric oxide for Post-operative period following cardiac surgery
  • Perampanel for White-Sutton syndrome (POGZ-related disorder)
  • Human IgG1 monoclonal antibody against human IL-1 beta and human IL-18 for Still's disease
  • Nivolumab for Triple-negative breast cancer (metastatic)
  • DOTINURAD for Gout | Hyperuricemia
  • Autologous T cells transduced with a retroviral vector encoding a chimeric antigen receptor against GD2, ex-vivo expanded for High-risk neuroblastoma | Relapsed/refractory neuroblastoma | GD2-positive tumors
  • ORZILOBEN for Intestinal failure-associated liver disease
  • Progesterone, micronised for Menopausal (climacteric) symptoms
  • PIT565 for Rheumatoid arthritis
  • Allogenic bone marrow-derived mesenchymal stem cells transduced with ICOVIR-5, ex vivo expanded for Autoimmune refractory epilepsy|Rasmussen encephalitis